Yuliia Akhatova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yuliia Akhatova has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Olga Gorina
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine
5 shared publications - Ivan Shcheniavskyi
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv, Ukraine
4 shared publications - Nataliia Moisieieva
Institute of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 23 Pereyaslavska st, 61016, Kharkiv, Ukraine
4 shared publications - Anton Moisieiev
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine
1 shared publication Nataliia Moisieieva
Institute for Problems of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, Kharkiv
1 shared publicationO. L. Horina
Institute of Cryobiology and Cryomedicine of the National Academy of Sciences of Ukraine, 23 Pereyaslavska st, 61016, Kharkiv, Ukraine
1 shared publication
Latest Publications
- Open Access
- 25 June 2026
- Published by V. N. Karazin Kharkiv National University in Biophysical Bulletin
- No. 55,p. 44-52
Regulatory effect of а synthetic opioid neuropeptid on protein homeostasis under cold stress conditions
Background: Opioid neuropeptides are capable of regulating metabolic processes through the activation of specific opioid receptors, particularly under stress conditions. However, the mechanisms of their impact on protein metabolism under chronic cold stress (CCS) remain insufficiently studied. Given the importance of maintaining protein homeostasis under extreme conditions, investigating the role of neuropeptides in correcting protein profiles is of practical significance for developing new approaches to pharmacological adaptation. Objective: To investigate changes in protein metabolism in the serum of guinea pigs under chronic cold stress, assess the protective effects of dalargin, and determine the role of the opioid system in regulating these processes. Materials and Methods: The study involved guinea pigs exposed to CCS conditions. Changes in protein metabolism were assessed by measuring total protein, albumin, and globulins in the serum using standard biochemical methods. A synthetic leu-enkephalin analog (dalargin) was used as a corrective agent and administered subcutaneously at a dose of 100 µg/kg 30 min before CCS induction. Results. In animals exposed to CCS, a statistically significant decrease in albumin levels and an increase in globulin levels were observed compared with intact values, which led to a disruption of the albumin–globulin ratio and indicated an imbalance in protein metabolism. Administration of dalargin contributed to normalization of the albumin–globulin ratio by restoring globulin and albumin levels in the blood of experimental animals, indicating stabilization of protein homeostasis and a protective effect of dalargin under conditions of CCS. In addition, administration of dalargin reduced the accumulation of malondialdehyde (MDA) under conditions of cold stress, demonstrating antioxidant and cytoprotective effects and ensuring the maintenance of structural and functional integrity of tissues. Conclusions. The study results suggest that dalargin is a promising agent for the pharmacological correction of metabolic disturbances induced by chronic cold stress, as it reduces MDA accumulation, exhibiting antioxidant and cytoprotective effects, and highlight the important role of the opioid neuropeptide system in the regulation of protein metabolism and maintenance of tissue structural integrity under extreme environmental conditions.
- 25 June 2026
- Published by V. N. Karazin Kharkiv National University in Biophysical Bulletin
- No. 55,p. 44-52
Open AccessRegulatory effect of а synthetic opioid neuropeptid on protein homeostasis under cold stress conditions
Background: Opioid neuropeptides are capable of regulating metabolic processes through the activation of specific opioid receptors, particularly under stress conditions. However, the mechanisms of their impact on protein metabolism under chronic cold stress (CCS) remain insufficiently studied. Given the importance of maintaining protein homeostasis under extreme conditions, investigating the role of neuropeptides in correcting protein profiles is of practical significance for developing new approaches to pharmacological adaptation. Objective: To investigate changes in protein metabolism in the serum of guinea pigs under chronic cold stress, assess the protective effects of dalargin, and determine the role of the opioid system in regulating these processes. Materials and Methods: The study involved guinea pigs exposed to CCS conditions. Changes in protein metabolism were assessed by measuring total protein, albumin, and globulins in the serum using standard biochemical methods. A synthetic leu-enkephalin analog (dalargin) was used as a corrective agent and administered subcutaneously at a dose of 100 µg/kg 30 min before CCS induction. Results. In animals exposed to CCS, a statistically significant decrease in albumin levels and an increase in globulin levels were observed compared with intact values, which led to a disruption of the albumin–globulin ratio and indicated an imbalance in protein metabolism. Administration of dalargin contributed to normalization of the albumin–globulin ratio by restoring globulin and albumin levels in the blood of experimental animals, indicating stabilization of protein homeostasis and a protective effect of dalargin under conditions of CCS. In addition, administration of dalargin reduced the accumulation of malondialdehyde (MDA) under conditions of cold stress, demonstrating antioxidant and cytoprotective effects and ensuring the maintenance of structural and functional integrity of tissues. Conclusions. The study results suggest that dalargin is a promising agent for the pharmacological correction of metabolic disturbances induced by chronic cold stress, as it reduces MDA accumulation, exhibiting antioxidant and cytoprotective effects, and highlight the important role of the opioid neuropeptide system in the regulation of protein metabolism and maintenance of tissue structural integrity under extreme environmental conditions.
- 30 June 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (2) , 85-91
Antioxidant and antihypoxic activity of human cord blood extracts obtained with various temperature regimens of destruction of cellular elements and extraction media
The research analysed the dependence of antioxidant and antihypoxic activity of human cord blood (HCB) extracts on the temperature regimen of destruction, salt composition and pH of the extraction solution. Using the adrenaline autooxidation model, it was found that the antiradical activity of all the cryoextracts exceeded this index of those obtained using the same extraction solutions in combination with incubation at 70 ºС for 30 min, or with the use of hypotonic lysis. The content of malondialdehyde and lipid hydroperoxides in the brain of animals exposed to normobaric hypoxia, which were injected with a low-molecular fraction (up to 10 kDa) isolated from HCB cryoextracts, was found to be significantly lower than when being injected with a low-molecular fraction of extracts obtained using high temperature or hypotonic lysis. During hypotonic lysis, enzyme molecules and low-molecular biologically active peptides also undergo significant destructive effects of endogenous proteases and lose their specific activity. It has been proven that cryoextraction, regardless of the applied freeze-thawing rates and the composition and pH of the medium, allows obtaining fi nal products with signifi cantly higher antiradical and anti-hypoxic properties than after holding at high temperature and hypotonic lysis. Our findings prove the prospects of using cryotechnologies in the processing animal and human tissues and blood to obtain raw materials enriched with biologically active substances to produce medicines.
- 30 June 2025
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 35 (2) , 85-91
Antioxidant and antihypoxic activity of human cord blood extracts obtained with various temperature regimens of destruction of cellular elements and extraction media
The research analysed the dependence of antioxidant and antihypoxic activity of human cord blood (HCB) extracts on the temperature regimen of destruction, salt composition and pH of the extraction solution. Using the adrenaline autooxidation model, it was found that the antiradical activity of all the cryoextracts exceeded this index of those obtained using the same extraction solutions in combination with incubation at 70 ºС for 30 min, or with the use of hypotonic lysis. The content of malondialdehyde and lipid hydroperoxides in the brain of animals exposed to normobaric hypoxia, which were injected with a low-molecular fraction (up to 10 kDa) isolated from HCB cryoextracts, was found to be significantly lower than when being injected with a low-molecular fraction of extracts obtained using high temperature or hypotonic lysis. During hypotonic lysis, enzyme molecules and low-molecular biologically active peptides also undergo significant destructive effects of endogenous proteases and lose their specific activity. It has been proven that cryoextraction, regardless of the applied freeze-thawing rates and the composition and pH of the medium, allows obtaining fi nal products with signifi cantly higher antiradical and anti-hypoxic properties than after holding at high temperature and hypotonic lysis. Our findings prove the prospects of using cryotechnologies in the processing animal and human tissues and blood to obtain raw materials enriched with biologically active substances to produce medicines.
- Open Access
- 24 May 2024
- Published by European Scientific Platform (Publications)
- No. May 24, 20,p. 121-123
CORRECTION OF HORMONAL DISORDERS INDUCED BY CHRONIC COLD STRESS USING SYNTHETIC NEUROPEPTIDE
Cold adaptation is considered one of the most difficult types of adaptation for an organism. This is caused by the very slow development of the cold adaptation process, which is accompanied by hormonal imbalance, changes in the metabolism of adipose tissue, deterioration of the body's protective properties, increased susceptibility to new diseases, and exacerbation of chronic diseases. Various adaptogens are used to prevent and correct the negative effects of cold stress. Adaptogens are able to prevent the activation of lipid peroxidation and energy depletion, support hormonal balance, and thus increase the body's resistance to cold exposure. Similar properties are characteristic of regulatory neuropeptides, including natural and synthetic opioids, which have a wide spectrum of regulatory activity and are able to prevent apoptosis [1, 2]. Research on the protective effect of opioids attracts special attention, since some of them take part in the endogenous regulation of seasonal physiological changes in hibernating animals [3]. One of these peptides is a synthetic analogue of leu-enkephalin, dalargin. It is known that leu-enkephalins have a membrane-stabilizing effect during hypothermia, and dalargin has the ability to reduce cortisol and catecholamines release, help to increase immune protection, reduce lipid peroxidation intensity, and prevent apoptosis of various cell types [2]. However, despite many studies in this area, the question of the possible protective effect of synthetic neuropeptides on cold adaptation, thermoregulation, and adipose tissue metabolism remains relevant. In this regard, the aim of our study was to evaluate the effect of dalargin on leptin and cortisol serum levels in guinea pigs subjected to chronic cold stress.
- 24 May 2024
- Published by European Scientific Platform (Publications)
- No. May 24, 20,p. 121-123
Open AccessCORRECTION OF HORMONAL DISORDERS INDUCED BY CHRONIC COLD STRESS USING SYNTHETIC NEUROPEPTIDE
Cold adaptation is considered one of the most difficult types of adaptation for an organism. This is caused by the very slow development of the cold adaptation process, which is accompanied by hormonal imbalance, changes in the metabolism of adipose tissue, deterioration of the body's protective properties, increased susceptibility to new diseases, and exacerbation of chronic diseases. Various adaptogens are used to prevent and correct the negative effects of cold stress. Adaptogens are able to prevent the activation of lipid peroxidation and energy depletion, support hormonal balance, and thus increase the body's resistance to cold exposure. Similar properties are characteristic of regulatory neuropeptides, including natural and synthetic opioids, which have a wide spectrum of regulatory activity and are able to prevent apoptosis [1, 2]. Research on the protective effect of opioids attracts special attention, since some of them take part in the endogenous regulation of seasonal physiological changes in hibernating animals [3]. One of these peptides is a synthetic analogue of leu-enkephalin, dalargin. It is known that leu-enkephalins have a membrane-stabilizing effect during hypothermia, and dalargin has the ability to reduce cortisol and catecholamines release, help to increase immune protection, reduce lipid peroxidation intensity, and prevent apoptosis of various cell types [2]. However, despite many studies in this area, the question of the possible protective effect of synthetic neuropeptides on cold adaptation, thermoregulation, and adipose tissue metabolism remains relevant. In this regard, the aim of our study was to evaluate the effect of dalargin on leptin and cortisol serum levels in guinea pigs subjected to chronic cold stress.
- 16 July 2023
- Published by Springer Nature
- p. 87-93
Expediency of Using a Physical and Mathematical Model in Cell Engineering
- 16 July 2023
- Published by Springer Nature
- p. 87-93
Expediency of Using a Physical and Mathematical Model in Cell Engineering
- Open Access
- 30 June 2021
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 31 (2) , 116-126
Comparative Evaluation of Wound Healing Effect of Cord Blood Low Molecular Weight Fraction (Below 5 kDa) and Actovegin Drug in Skin Cryolesions
This paper presents the results of comparative studies of the impact of the low molecular weight (below 5 kDa) cattle cord blood fraction (CBF) and the comparator drug Actovegin on tissue regeneration after skin cryoablation in rats. Here, a local contact cryoexposure was shown to result not only in destruction of all skin layers, but secondary ischemic damage to deeper and adjacent tissues as well. The use of an injection solution of CBF as a therapy for simulated cryolesion proved its pronounced wound healing effect, manifested in accelerated reparation, improved trophicity in an injured area due to hypervascularization and prevention of sclerotic processes. The introduction of CBF and Actovegin to rats accelerated the normalization of clinical blood parameters (RBC and WBC counts, alkaline phosphatase activity) in shorter terms as compared with the control. The obtained effect may be compared with Actovegin action.
- 30 June 2021
- Published by National Academy of Sciences of Ukraine (Co. LTD Ukrinformnauka) (Publications) in Problems of Cryobiology and Cryomedicine
- Vol. 31 (2) , 116-126
Open AccessComparative Evaluation of Wound Healing Effect of Cord Blood Low Molecular Weight Fraction (Below 5 kDa) and Actovegin Drug in Skin Cryolesions
This paper presents the results of comparative studies of the impact of the low molecular weight (below 5 kDa) cattle cord blood fraction (CBF) and the comparator drug Actovegin on tissue regeneration after skin cryoablation in rats. Here, a local contact cryoexposure was shown to result not only in destruction of all skin layers, but secondary ischemic damage to deeper and adjacent tissues as well. The use of an injection solution of CBF as a therapy for simulated cryolesion proved its pronounced wound healing effect, manifested in accelerated reparation, improved trophicity in an injured area due to hypervascularization and prevention of sclerotic processes. The introduction of CBF and Actovegin to rats accelerated the normalization of clinical blood parameters (RBC and WBC counts, alkaline phosphatase activity) in shorter terms as compared with the control. The obtained effect may be compared with Actovegin action.